Will This Analyst Upgrade Help Envision Healthcare (EVHC) Stock Today?

NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Want to Buy $1 Worth of Stock for 90 Cents or Less?

Want to Buy $1 Worth of Stock for 90 Cents or Less?

Comcast Tops Disney/Fox in $40 Billion Battle for Britain's Sky TV

Comcast Tops Disney/Fox in $40 Billion Battle for Britain's Sky TV

The Products Behind Smokin' Hot Tilray

The Products Behind Smokin' Hot Tilray

FANGs Aren't Tech Stocks Any More: S&P Overhauls Sector Breakdowns

FANGs Aren't Tech Stocks Any More: S&P Overhauls Sector Breakdowns

How to Overcome the Fear of Trading Super-Momentum Stocks

How to Overcome the Fear of Trading Super-Momentum Stocks